International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States

The mammalian bombesin receptor family comprises three G protein-coupled heptahelical receptors: the neuromedin B (NMB) receptor (BB1), the gastrin-releasing peptide (GRP) receptor (BB2), and the orphan receptor bombesin receptor subtype 3 (BRS-3) (BB3). Each receptor is widely distributed, especially in the gastrointestinal (GI) tract and central nervous system (CNS), and the receptors have a large range of effects in both normal physiology and pathophysiological conditions. The mammalian bombesin peptides, GRP and NMB, demonstrate a broad spectrum of pharmacological/biological responses. GRP stimulates smooth muscle contraction and GI motility, release of numerous GI hormones/neurotransmitters, and secretion and/or hormone release from the pancreas, stomach, colon, and numerous endocrine organs and has potent effects on immune cells, potent growth effects on both normal tissues and tumors, potent CNS effects, including regulation of circadian rhythm, thermoregulation; anxiety/fear responses, food intake, and numerous CNS effects on the GI tract as well as the spinal transmission of chronic pruritus. NMB causes contraction of smooth muscle, has growth effects in various tissues, has CNS effects, including effects on feeding and thermoregulation, regulates thyroid-stimulating hormone release, stimulates various CNS neurons, has behavioral effects, and has effects on spinal sensory transmission. GRP, and to a lesser extent NMB, affects growth and/or differentiation of various human tumors, including colon, prostate, lung, and some gynecologic cancers. Knockout studies show that BB3 has important effects in energy balance, glucose homeostasis, control of body weight, lung development and response to injury, tumor growth, and perhaps GI motility. This review summarizes advances in our understanding of the biology/pharmacology of these receptors, including their classification, structure, pharmacology, physiology, and role in pathophysiological conditions.

[1]  A. Schally,et al.  Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi. , 2009, International journal of peptide and protein research.

[2]  J. Bali,et al.  Synthesis of pseudo-peptide analogues of the C-terminal tetrapeptide of gastrin and evaluation of their biological activity on acid secretion. , 2009, International journal of peptide and protein research.

[3]  M. Schubert,et al.  Gastric secretion , 2008, Current opinion in gastroenterology.

[4]  J. Crapo,et al.  Bombesin-like peptides modulate alveolarization and angiogenesis in bronchopulmonary dysplasia. , 2007, American journal of respiratory and critical care medicine.

[5]  G. Baldwin,et al.  Phylogenetic analysis of the sequences of gastrin-releasing peptide and its receptors: Biological implications , 2007, Regulatory Peptides.

[6]  L. Christiansen,et al.  Evidence for the association of the S100β gene with low cognitive performance and dementia in the elderly , 2007, Molecular Psychiatry.

[7]  R. Roesler,et al.  Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  F. McGlone,et al.  Chronic itch and chronic pain: Analogous mechanisms , 2007, Pain.

[9]  J. Speakman,et al.  Expression of neuromedin B in adipose tissue and its regulation by changes in energy balance. , 2007, Journal of molecular endocrinology.

[10]  G. Baldwin,et al.  Recombinant C-terminal fragments of the gastrin-releasing peptide precursor are bioactive. , 2007, Cancer letters.

[11]  A. Schally,et al.  Targeted therapy of breast and gynecological cancers with cytotoxic analogues of peptide hormones. , 2007, Molecular pharmaceutics.

[12]  J. Reubi,et al.  Overexpression of Gastrin-Releasing Peptide Receptors in Tumor-Associated Blood Vessels of Human Ovarian Neoplasms , 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[13]  Yan-Gang Sun,et al.  A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord , 2007, Nature.

[14]  Timothy J. Hoffman,et al.  In Vivo Evaluation and Small-Animal PET/CT of a Prostate Cancer Mouse Model Using 64Cu Bombesin Analogs: Side-by-Side Comparison of the CB-TE2A and DOTA Chelation Systems , 2007, Journal of Nuclear Medicine.

[15]  Peter Hohenberger,et al.  68Ga-Labeled Bombesin Studies in Patients with Gastrointestinal Stromal Tumors: Comparison with 18F-FDG , 2007, Journal of Nuclear Medicine.

[16]  S. Figueroa,et al.  [64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues , 2007, Proceedings of the National Academy of Sciences.

[17]  E. Mintz,et al.  Gastrin releasing peptide and neuropeptide Y exert opposing actions on circadian phase , 2007, Neuroscience Letters.

[18]  Hui-jun Liu,et al.  PPARα and AP-2α regulate bombesin receptor subtype 3 expression in ozone-stressed bronchial epithelial cells , 2007 .

[19]  Å. Svensson,et al.  Self reported skin morbidity and ethnicity: a population-based study in a Western community , 2007, BMC dermatology.

[20]  E. Rozengurt,et al.  Protein kinase D2 potentiates MEK/ERK/RSK signaling, c‐Fos accumulation and DNA synthesis induced by bombesin in Swiss 3T3 cells , 2007, Journal of cellular physiology.

[21]  E. Ladenheim,et al.  Capsaicin treatment differentially affects feeding suppression by bombesin-like peptides , 2007, Physiology & Behavior.

[22]  T. Visser,et al.  Radiolabelled regulatory peptides for imaging and therapy. , 2007, Anti-cancer agents in medicinal chemistry.

[23]  Zul Merali,et al.  Role of gastrin-releasing peptide and neuromedin B in anxiety and fear-related behavior , 2007, Behavioural Brain Research.

[24]  J. Siegfried,et al.  Gastrin-releasing peptide activates Akt through the epidermal growth factor receptor pathway and abrogates the effect of gefitinib. , 2007, Experimental cell research.

[25]  Jill M. Siegfried,et al.  Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer , 2007, Molecular Cancer Therapeutics.

[26]  F. Dalgard,et al.  Are Itch and Chronic Pain Associated in Adults? Results of a Large Population Survey in Norway , 2007, Dermatology.

[27]  G. Baldwin,et al.  C-terminal fragments of the gastrin-releasing peptide precursor stimulate cell proliferation via a novel receptor. , 2007, Endocrinology.

[28]  K. Haruma,et al.  Bombesin prevents the atrophy of Peyer's patches and the dysfunction of M cells in rabbits receiving long-term parenteral nutrition. , 2007, JPEN. Journal of parenteral and enteral nutrition.

[29]  R. Roesler,et al.  Impairments of social behavior and memory after neonatal gastrin-releasing peptide receptor blockade in rats: Implications for an animal model of neurodevelopmental disorders , 2007, Neuropharmacology.

[30]  F. Forrer,et al.  Peptide receptor radionuclide therapy , 2007 .

[31]  R. Gainetdinov,et al.  Physiological roles of G protein-coupled receptor kinases and arrestins. , 2007, Annual review of physiology.

[32]  A. Coran,et al.  Bombesin stimulates enterocyte turnover following massive small bowel resection in a rat , 2007, Pediatric Surgery International.

[33]  E. Krenning,et al.  Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[34]  M. Eisenhut,et al.  DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[35]  L. Lénárd,et al.  Neuromedin C microinjected into the amygdala inhibits feeding , 2007, Brain Research Bulletin.

[36]  R. Valkema,et al.  Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours , 2007, Acta oncologica.

[37]  A. Nunn,et al.  Lutetium-177-labeled gastrin releasing peptide receptor binding analogs: a novel approach to radionuclide therapy. , 2006, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[38]  R. Jensen,et al.  Identification of Bombesin Receptor Subtype-Specific Ligands: Effect of N-Methyl Scanning, Truncation, Substitution, and Evaluation of Putative Reported Selective Ligands , 2006, Journal of Pharmacology and Experimental Therapeutics.

[39]  A. Harada,et al.  Activation of bombesin receptor subtype-3 stimulates adhesion of lung cancer cells. , 2006, Lung cancer.

[40]  H. Anisman,et al.  Bombesin Receptors as a Novel Anti-Anxiety Therapeutic Target: BB1 Receptor Actions on Anxiety through Alterations of Serotonin Activity , 2006, The Journal of Neuroscience.

[41]  N. Sugimoto,et al.  Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase , 2006, Oncogene.

[42]  S. Schulz,et al.  Immunohistochemical detection of bombesin receptor subtypes GRP-R and BRS-3 in human tumors using novel antipeptide antibodies , 2006, Virchows Archiv.

[43]  R. Jensen,et al.  In Vitro and in Vivo Antitumor Effects of Cytotoxic Camptothecin-Bombesin Conjugates Are Mediated by Specific Interaction with Cellular Bombesin Receptors , 2006, Journal of Pharmacology and Experimental Therapeutics.

[44]  R. Roesler,et al.  Opposite effects of low and high doses of the gastrin-releasing peptide receptor antagonist RC-3095 on memory consolidation in the hippocampus: Possible involvement of the GABAergic system , 2006, Peptides.

[45]  G. Baldwin,et al.  Gastrin-releasing peptide and cancer. , 2006, Biochimica et biophysica acta.

[46]  I. Izquierdo,et al.  Molecular mechanisms mediating gastrin-releasing peptide receptor modulation of memory consolidation in the hippocampus , 2006, Neuropharmacology.

[47]  A. Schally,et al.  Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormone-releasing hormone and their combinations , 2006, Proceedings of the National Academy of Sciences.

[48]  Thangavel Arunachalam,et al.  177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[49]  Xiang Li,et al.  Wound repair and proliferation of bronchial epithelial cells enhanced by bombesin receptor subtype 3 activation , 2006, Peptides.

[50]  N. Iwai,et al.  Prevention of warm ischemic injury by neuropeptide bombesin in small bowel transplantation. , 2006, Transplantation proceedings.

[51]  N. Iwai,et al.  Neuroendocrine-immune modulation may be useful for allograft-specific immunosuppression in small bowel transplantation. , 2006, Transplantation proceedings.

[52]  N. Iwai,et al.  FK506 induces the atrophy of enteric ganglia in small bowel transplantation, which can be prevented by the neuropeptide bombesin. , 2006, Transplantation proceedings.

[53]  I. Izquierdo,et al.  A role for hippocampal gastrin-releasing peptide receptors in extinction of aversive memory , 2006, Neuroreport.

[54]  K. Wada,et al.  Bombesin inhibits alveolarization and promotes pulmonary fibrosis in newborn mice. , 2006, American journal of respiratory and critical care medicine.

[55]  Alfred Martinez A new family of angiogenic factors. , 2006, Cancer letters.

[56]  M. Perry,et al.  Evaluation of combined (177)Lu-DOTA-8-AOC-BBN (7-14)NH(2) GRP receptor-targeted radiotherapy and chemotherapy in PC-3 human prostate tumor cell xenografted SCID mice. , 2006, Cancer biotherapy & radiopharmaceuticals.

[57]  R. Benya,et al.  Consequence of gastrin-releasing peptide receptor activation in a human colon cancer cell line: a proteomic approach. , 2006, Journal of proteome research.

[58]  A. Safavy,et al.  Single-drug multiligand conjugates: synthesis and preliminary cytotoxicity evaluation of a paclitaxel-dipeptide "scorpion" molecule. , 2006, Bioconjugate chemistry.

[59]  R. Jensen,et al.  The Src family kinase, Lyn, is activated in pancreatic acinar cells by gastrointestinal hormones/neurotransmitters and growth factors which stimulate its association with numerous other signaling molecules. , 2006, Biochimica et biophysica acta.

[60]  C. Nanni,et al.  18F-DOPA PET/CT and neuroendocrine tumours , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[61]  R. Roesler,et al.  Gastrin-releasing peptide receptor as a molecular target for psychiatric and neurological disorders. , 2006, CNS & neurological disorders drug targets.

[62]  Eduard Schreibmann,et al.  18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[63]  P. Pohlmann,et al.  A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies , 2006, Investigational New Drugs.

[64]  H. Ohki‐Hamazaki,et al.  Disruption of neuromedin B receptor gene results in dysregulation of the pituitary-thyroid axis. , 2006, Journal of molecular endocrinology.

[65]  B. McEwen,et al.  Diurnal regulation of the gastrin‐releasing peptide receptor in the mouse circadian clock , 2006, The European journal of neuroscience.

[66]  A. Schally,et al.  Targeted cytotoxic bombesin analog AN-215 effectively inhibits experimental human breast cancers with a low induction of multi-drug resistance proteins. , 2005, Endocrine-related cancer.

[67]  N. Iwai,et al.  Preoperative bombesin administration can protect the rat small bowel allograft from ischemic reperfusion injury. , 2005, Journal of pediatric surgery.

[68]  C. Vagianos,et al.  Effect of bombesin and neurotensin on gut barrier function in partially hepatectomized rats. , 2005, World journal of gastroenterology.

[69]  Y. Wong,et al.  Gq-Mediated Activation of c-Jun N-Terminal Kinase by the Gastrin-Releasing Peptide-Preferring Bombesin Receptor Is Inhibited upon Costimulation of the Gs-Coupled Dopamine D1 Receptor in COS-7 Cells , 2005, Molecular Pharmacology.

[70]  R. Massari,et al.  Fast cancer uptake of 99mTc-labelled bombesin (99mTc BN1). , 2005, In vivo.

[71]  C. Albanese,et al.  Bombesin regulates cyclin D1 expression through the early growth response protein Egr-1 in prostate cancer cells. , 2005, Cancer research.

[72]  T. Hoffman,et al.  Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes. , 2005, Nuclear medicine and biology.

[73]  K. Yonemori,et al.  Pro‐gastrin–releasing peptide as a factor predicting the incidence of brain metastasis in patients with small cell lung carcinoma with limited disease receiving prophylactic cranial irradiation , 2005, Cancer.

[74]  A. Schally,et al.  Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC‐3 and DU‐145 human androgen‐independent prostate cancers , 2005, The Prostate.

[75]  J. Reubi,et al.  Gastrin-releasing peptide receptors in normal and neoplastic human uterus: involvement of multiple tissue compartments. , 2005, The Journal of clinical endocrinology and metabolism.

[76]  T. Schlott,et al.  Expression of gastrin releasing Peptide receptor in renal cell carcinomas: a potential function for the regulation of neoangiogenesis and microvascular perfusion. , 2005, The Journal of urology.

[77]  R. Benya,et al.  Transient upregulation of GRP and its receptor critically regulate colon cancer cell motility during remodeling. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[78]  Sarah Glover,et al.  Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[79]  J. Siegfried,et al.  Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells. , 2005, Neoplasia.

[80]  K. Wada,et al.  The design of a new potent and selective ligand for the orphan bombesin receptor subtype 3 (BRS3) , 2005, Journal of peptide science : an official publication of the European Peptide Society.

[81]  B. Bonaz,et al.  Bombesin receptor subtype-3 is expressed by the enteric nervous system and by interstitial cells of Cajal in the rat gastrointestinal tract , 2005, Cell and Tissue Research.

[82]  R. Jensen,et al.  Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP). , 2005, Biochemical pharmacology.

[83]  A. Schally,et al.  Antagonists of bombesin/gastrin-releasing peptide decrease the expression of angiogenic and anti-apoptotic factors in human glioblastoma , 2005, Anti-cancer drugs.

[84]  K. Wada,et al.  Immunohistochemical localization of gastrin-releasing peptide receptor in the mouse brain , 2005, Brain Research.

[85]  R. Baudinette,et al.  An immunomodulator used to protect young in the pouch of the Tammar wallaby, Macropus eugenii , 2005, The FEBS journal.

[86]  C. Vagianos,et al.  Bombesin and Neurotensin Reduce Endotoxemia, Intestinal Oxidative Stress, and Apoptosis in Experimental Obstructive Jaundice , 2005, Annals of surgery.

[87]  C. Bouchard,et al.  Neuromedin beta: a strong candidate gene linking eating behaviors and susceptibility to obesity. , 2004, The American journal of clinical nutrition.

[88]  G. Baldwin,et al.  Stimulation of proliferation and migration of a colorectal cancer cell line by amidated and glycine-extended gastrin-releasing peptide via the same receptor. , 2004, Biochemical pharmacology.

[89]  Jiehua Zhou,et al.  Targeting gastrin-releasing peptide receptors for cancer treatment , 2004, Anti-cancer drugs.

[90]  C. Lamers,et al.  Gastrin releasing peptide receptor expression is decreased in patients with Crohn’s disease but not in ulcerative colitis , 2004, Journal of Clinical Pathology.

[91]  G. Baldwin,et al.  Developmental expression and biological activity of gastrin-releasing peptide and its receptors in the kidney. , 2004, American journal of physiology. Renal physiology.

[92]  R. Jensen,et al.  Development of Bombesin Analogs with Conformationally Restricted Amino Acid Substitutions with Enhanced Selectivity for the Orphan Receptor Human Bombesin Receptor Subtype 3 , 2004, Journal of Pharmacology and Experimental Therapeutics.

[93]  A. Schally,et al.  Chemotherapy targeted to cancers through tumoral hormone receptors , 2004, Trends in Endocrinology & Metabolism.

[94]  J. Grider Gastrin-releasing peptide is a modulatory neurotransmitter of the descending phase of the peristaltic reflex. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[95]  E. Corazziari,et al.  Detection of colon cancer with 99mTc-labeled bombesin derivative (99mTc-leu13-BN1). , 2004, Cancer biotherapy & radiopharmaceuticals.

[96]  G. de Vincentis,et al.  Role of 99mTc-bombesin scan in diagnosis and staging of prostate cancer. , 2004, Cancer biotherapy & radiopharmaceuticals.

[97]  M. Reitman,et al.  Characterization of the bombesin-like peptide receptor family in primates. , 2004, Genomics.

[98]  E. Rozengurt,et al.  Insulin reduces the requirement for EGFR transactivation in bombesin-induced DNA synthesis. , 2004, Biochemical and biophysical research communications.

[99]  K. Wada,et al.  Functions of pancreatic beta cells and adipocytes in bombesin receptor subtype-3-deficient mice. , 2004, Biochemical and biophysical research communications.

[100]  R. Jensen,et al.  Development of High Affinity Camptothecin-Bombesin Conjugates That Have Targeted Cytotoxicity for Bombesin Receptor-containing Tumor Cells* , 2004, Journal of Biological Chemistry.

[101]  C. Vagianos,et al.  Experimental obstructive jaundice disrupts intestinal mucosal barrier by altering occludin expression: beneficial effect of bombesin and neurotensin. , 2004, Journal of the American College of Surgeons.

[102]  E. Rozengurt,et al.  Protein Kinase D Potentiates DNA Synthesis Induced by Gq-coupled Receptors by Increasing the Duration of ERK Signaling in Swiss 3T3 Cells* , 2004, Journal of Biological Chemistry.

[103]  R. Benya,et al.  Phosphorylation of focal adhesion kinase tyrosine 397 critically mediates gastrin‐releasing peptide's morphogenic properties , 2004, Journal of cellular physiology.

[104]  T. Moody,et al.  Bombesin-like peptides and associated receptors within the brain: distribution and behavioral implications , 2004, Peptides.

[105]  H. Ohki‐Hamazaki,et al.  Leptin resistance and enhancement of feeding facilitation by melanin-concentrating hormone in mice lacking bombesin receptor subtype-3. , 2004, Diabetes.

[106]  R. Jensen,et al.  Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours. , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[107]  I. Izquierdo,et al.  Bombesin/gastrin‐releasing peptide receptors in the basolateral amygdala regulate memory consolidation , 2004, The European journal of neuroscience.

[108]  E. Cartwright,et al.  Gastrin releasing peptide and gastrin releasing peptide receptor expression in gastrointestinal carcinoid tumours , 2004, Journal of Clinical Pathology.

[109]  A. Bajo,et al.  Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers , 2004, British Journal of Cancer.

[110]  J. Siegfried,et al.  Lung cancer-derived bombesin-like peptides down-regulate the generation and function of human dendritic cells , 2003, Journal of Neuroimmunology.

[111]  R. Jensen,et al.  Importance of Amino Acids of the Central Portion of the Second Intracellular Loop of the Gastrin-Releasing Peptide Receptor for Phospholipase C Activation, Internalization, and Chronic Down-Regulation , 2003, Journal of Pharmacology and Experimental Therapeutics.

[112]  N. Matsuura,et al.  Transactivation of epidermal growth factor receptor after heparin‐binding epidermal growth factor‐like growth factor shedding in the migration of prostate cancer cells promoted by bombesin , 2003, The Prostate.

[113]  T. Hoffman,et al.  Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update. , 2003, Nuclear medicine and biology.

[114]  E. Rozengurt,et al.  Galardin (GM 6001), a broad-spectrum matrix metalloproteinase inhibitor, blocks bombesin- and LPA-induced EGF receptor transactivation and DNA synthesis in rat-1 cells. , 2003, Experimental cell research.

[115]  M. Morales,et al.  Thyrotropin Secretagogues Reduce Rat Pituitary Neuromedin B, a Local Thyrotropin Release Inhibitor , 2003, Experimental biology and medicine.

[116]  X. Qu,et al.  Activation of extracellular signal-regulated kinase mediates bombesin-induced mitogenic responses in prostate cancer cells. , 2003, Cellular signalling.

[117]  J. Battey,et al.  Agonist- and protein kinase C-induced phosphorylation have similar functional consequences for gastrin-releasing peptide receptor signaling via Gq. , 2003, Molecular pharmacology.

[118]  J. Siegfried,et al.  Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor , 2003, Oncogene.

[119]  C. Wiedermann,et al.  Agonist function of the neurokinin receptor antagonist, [d-Arg1,d-Phe5,d-Trp7,9,Leu11]substance P, in monocytes , 2003, Regulatory Peptides.

[120]  Y. Miller,et al.  Bombesin-like peptides and mast cell responses: relevance to bronchopulmonary dysplasia? , 2003, American journal of respiratory and critical care medicine.

[121]  P. Maycox,et al.  The distribution of the orphan bombesin receptor subtype-3 in the rat cns , 2003, Neuroscience.

[122]  R. Jensen,et al.  Nonpeptide gastrin releasing peptide receptor antagonists inhibit the proliferation of lung cancer cells. , 2003, European journal of pharmacology.

[123]  M. R. Hellmich,et al.  Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells. , 2003, Cancer research.

[124]  K. Ui-Tei,et al.  Molecular cloning and characterization of avian bombesin‐like peptide receptors: new tools for investigating molecular basis for ligand selectivity , 2003, British journal of pharmacology.

[125]  R. Benya,et al.  Increased frequency of gastrin‐releasing peptide receptor gene mutations during colon‐adenocarcinoma progression , 2003, Molecular carcinogenesis.

[126]  H. Sarau,et al.  The neuromedin B receptor antagonist, BIM‐23127, is a potent antagonist at human and rat urotensin‐II receptors , 2003, British journal of pharmacology.

[127]  B. Yeğen Bombesin-like peptides: candidates as diagnostic and therapeutic tools. , 2003, Current pharmaceutical design.

[128]  H. Kessler,et al.  Design of selective peptidomimetic agonists for the human orphan receptor BRS-3. , 2003, Journal of medicinal chemistry.

[129]  R. Valkema,et al.  Radiolabelled peptides for tumour therapy: current status and future directions , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[130]  K. Wada,et al.  Stress-induced impairment of inhibitory avoidance learning in female neuromedin B receptor-deficient mice , 2003, Physiology & Behavior.

[131]  T. Ortiga-Carvalho,et al.  The autocrine/paracrine regulation of thyrotropin secretion. , 2003, Thyroid : official journal of the American Thyroid Association.

[132]  G. Loudos,et al.  [99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[133]  K. Wada,et al.  Bombesin receptor subtype-3 modulates plasma insulin concentration , 2003, Peptides.

[134]  R. Jensen,et al.  Neuropeptides as autocrine growth factors in cancer cells. , 2003, Current pharmaceutical design.

[135]  Eric R. Kandel,et al.  Identification of a Signaling Network in Lateral Nucleus of Amygdala Important for Inhibiting Memory Specifically Related to Learned Fear , 2002, Cell.

[136]  T. Visser,et al.  Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[137]  G. Pacini,et al.  Islet function phenotype in gastrin-releasing peptide receptor gene-deficient mice. , 2002, Endocrinology.

[138]  K. Wada,et al.  Restraint stress impaired maternal behavior in female mice lacking the neuromedin B receptor (NMB-R) gene , 2002, Neuroscience Letters.

[139]  J. Nathan,et al.  Neurohormonal control of pancreatic exocrine secretion , 2002, Current opinion in gastroenterology.

[140]  J. Battey,et al.  Disruptions in feeding and body weight control in gastrin-releasing peptide receptor deficient mice. , 2002, The Journal of endocrinology.

[141]  Horst Kessler,et al.  Systematic optimization of a lead‐structure identities for a selective short peptide agonist for the human orphan receptor BRS‐3 , 2002, Journal of peptide science : an official publication of the European Peptide Society.

[142]  L. V. D. van der Ploeg,et al.  Molecular basis of the pharmacological difference between rat and human bombesin receptor subtype-3 (BRS-3). , 2002, Biochemistry.

[143]  R. Jensen,et al.  Molecular basis of the selectivity of gastrin-releasing peptide receptor for gastrin-releasing peptide. , 2002, Molecular pharmacology.

[144]  D. Chung,et al.  Gastrin-Releasing Peptide Is a Growth Factor for Human Neuroblastomas , 2002, Annals of surgery.

[145]  R. Benya,et al.  Contribution of gastrin-releasing peptide and its receptor to villus development in the murine and human gastrointestinal tract , 2002, Mechanisms of Development.

[146]  H. Ogura,et al.  Modulation of 5‐HT system in mice with a targeted disruption of neuromedin B receptor , 2002, Journal of neuroscience research.

[147]  J. Reubi,et al.  Bombesin Receptor Subtypes in Human Cancers: Detection with the Universal Radioligand 125I-[d-TYR6, β-ALA11, PHE13, NLE14] Bombesin(6–14) , 2002 .

[148]  J. Siegfried,et al.  Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck. , 2002, Journal of the National Cancer Institute.

[149]  H. Anisman,et al.  Role of bombesin-related peptides in the mediation or integration of the stress response , 2002, Cellular and Molecular Life Sciences CMLS.

[150]  M. Singer,et al.  Central and peripheral neural control of pancreatic exocrine secretion. , 2001, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[151]  R. Jensen,et al.  Molecular Basis for Selectivity of High Affinity Peptide Antagonists for the Gastrin-releasing Peptide Receptor* , 2001, The Journal of Biological Chemistry.

[152]  E. Rozengurt,et al.  EGF receptor function is required in late G(1) for cell cycle progression induced by bombesin and bradykinin. , 2001, American journal of physiology. Cell physiology.

[153]  G. Frank,et al.  Reduced gastrin releasing peptide in cerebrospinal fluid after recovery from bulimia nervosa , 2001, Appetite.

[154]  Christopher Haslett,et al.  Bombesin and Substance P Analogues Differentially Regulate G-protein Coupling to the Bombesin Receptor , 2001, The Journal of Biological Chemistry.

[155]  C. Beglinger,et al.  Regulation of gastric function by endogenous gastrin releasing peptide in humans: studies with a specific gastrin releasing peptide receptor antagonist , 2001, Gut.

[156]  R. Benya,et al.  The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer , 2001, Peptides.

[157]  K. Kiura,et al.  Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC). , 2001, Lung cancer.

[158]  J. Knezetic,et al.  Receptors and Ligands for Autocrine Growth Pathways Are Up-regulated When Pancreatic Cancer Cells Are Adapted to Serum-Free Culture , 2001, Pancreas.

[159]  R. Jensen,et al.  Rational Design of a Peptide Agonist That Interacts Selectively with the Orphan Receptor, Bombesin Receptor Subtype 3* , 2001, The Journal of Biological Chemistry.

[160]  K. Wada,et al.  Female gastrin-releasing peptide receptor (GRP-R)-deficient mice exhibit altered social preference for male conspecifics: implications for GRP/GRP-R modulation of GABAergic function , 2001, Brain Research.

[161]  S. Ferguson,et al.  Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. , 2001, Pharmacological reviews.

[162]  D. Xiao,et al.  The human gastrin-releasing peptide receptor gene structure, its tissue expression and promoter. , 2001, Gene.

[163]  C. Beglinger,et al.  Blockade of GRP receptors inhibits gastric emptying and gallbladder contraction but accelerates small intestinal transit. , 2001, Gastroenterology.

[164]  R. Jensen,et al.  A bombesin receptor subtype-3 peptide increases nuclear oncogene expression in a MEK-1 dependent manner in human lung cancer cells. , 2001, European journal of pharmacology.

[165]  David H. Coy,et al.  Tyrosine 220 in the 5th Transmembrane Domain of the Neuromedin B Receptor Is Critical for the High Selectivity of the Peptoid Antagonist PD168368* , 2001, The Journal of Biological Chemistry.

[166]  R. Jensen,et al.  Nonpeptide neuromedin B receptor antagonists inhibit the proliferation of C6 cells. , 2000, European journal of pharmacology.

[167]  H. Friess,et al.  Bombesin Receptors in Distinct Tissue Compartments of Human Pancreatic Diseases , 2000, Laboratory Investigation.

[168]  A. Schally,et al.  in vivo inhibition of PC‐3 human androgen‐independent prostate cancer by a targeted cytotoxic bombesin analogue, AN‐215 , 2000, International journal of cancer.

[169]  J. Torday,et al.  Bombesin-like peptide and receptors in lung injury models: diverse gene expression, similar function☆,☆☆ 1 1 ☆☆ We are deeply grateful to Professor Vittorio Erspamer, whose vision and life’s work paved the way for these studies. , 2000, Peptides.

[170]  K. Wada,et al.  Reduced GLP-1 and insulin responses and glucose intolerance after gastric glucose in GRP receptor-deleted mice. , 2000, American journal of physiology. Endocrinology and metabolism.

[171]  Y. Taché,et al.  Bombesin and the brain-gut axis☆,1 , 2000, Peptides.

[172]  Hiroko Ohki-Hamazaki Neuromedin B , 2000, Progress in Neurobiology.

[173]  C. Beglinger,et al.  Blockade of GRP receptors inhibits gastric emptying and gallbladder contraction but accelerates small intestinal transit in humans , 2000, Regulatory Peptides.

[174]  A. Schally,et al.  Peptide analogs in the therapy of prostate cancer , 2000, The Prostate.

[175]  E. Rozengurt,et al.  [d-Arg1,d-Trp5,7,9,Leu11]Substance P Inhibits Bombesin-induced Mitogenic Signal Transduction Mediated by Both Gq and G12 in Swiss 3T3 Cells* , 2000, The Journal of Biological Chemistry.

[176]  R. Benya,et al.  Characterization of gastrin-releasing peptide and its receptor aberrantly expressed by human colon cancer cell lines. , 2000, Molecular pharmacology.

[177]  R. Jensen,et al.  Two amino acids in the sixth transmembrane segment of the mouse gastrin-releasing peptide receptor are important for receptor activation. , 2000, The Journal of pharmacology and experimental therapeutics.

[178]  K. Wada,et al.  Male mice lacking the gastrin-releasing peptide receptor (GRP-R) display elevated preference for conspecific odors and increased social investigatory behaviors , 2000, Brain Research.

[179]  R. Benya,et al.  Gastrin-releasing peptide is a mitogen and a morphogen in murine colon cancer. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[180]  A. Schally,et al.  The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers , 2000, Regulatory Peptides.

[181]  Z. Szallasi,et al.  Effect of a tyrosine 155 to phenylalanine mutation of protein kinase cdelta on the proliferative and tumorigenic properties of NIH 3T3 fibroblasts. , 2000, Carcinogenesis.

[182]  A. Schally,et al.  Presence of receptors for bombesin/gastrin‐releasing peptide and mRNA for three receptor subtypes in human prostate cancers , 2000, The Prostate.

[183]  R. Jensen,et al.  Molecular organization of the mouse gastrin-releasing peptide receptor gene and its promoter. , 2000, Gene.

[184]  H. Ohki‐Hamazaki,et al.  Differential effects of social isolation upon body weight, food consumption, and responsiveness to novel and social environment in bombesin receptor subtype-3 (BRS-3) deficient mice , 2000, Physiology & Behavior.

[185]  S. Yamashita,et al.  Mutation in Bombesin Receptor Subtype-3 Gene is not a Major Cause of Obesity in the Japanese , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[186]  J. Battey,et al.  Phosphorylation Uncouples the Gastrin-releasing Peptide Receptor from Gq * , 1999, The Journal of Biological Chemistry.

[187]  J. Primrose,et al.  Bombesin family receptor and ligand gene expression in human colorectal cancer and normal mucosa , 1999, British Journal of Cancer.

[188]  J C Reubi,et al.  Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast. , 1999, The American journal of pathology.

[189]  J. Torday,et al.  Bombesin-like peptides and receptors in normal fetal baboon lung: roles in lung growth and maturation. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[190]  S. Larson,et al.  Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[191]  J. Siegfried,et al.  Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer. , 1999, Pulmonary pharmacology & therapeutics.

[192]  H. Anisman,et al.  Role of bombesin-related peptides in the control of food intake , 1999, Neuropeptides.

[193]  R. Jensen,et al.  Comparative pharmacology of the nonpeptide neuromedin B receptor antagonist PD 168368. , 1999, The Journal of pharmacology and experimental therapeutics.

[194]  A. Shulkes,et al.  Molecular cloning, genomic organization and selective expression of bombesin receptor subtype 3 in the sheep hypothalamus and pituitary. , 1999, Journal of molecular endocrinology.

[195]  N. Sunaga,et al.  Serum Pro-Gastrin-Releasing Peptide Is a Useful Marker for Treatment Monitoring and Survival in Small-Cell Lung Cancer , 1999, Oncology.

[196]  R. Jensen,et al.  An aspartate residue at the extracellular boundary of TMII and an arginine residue in TMVII of the gastrin-releasing peptide receptor interact to facilitate heterotrimeric G protein coupling. , 1999, Biochemistry.

[197]  J P Vincent,et al.  Neurotensin and neurotensin receptors. , 1999, Trends in pharmacological sciences.

[198]  H. Ohki‐Hamazaki,et al.  Hyperresponsiveness to Palatable and Aversive Taste Stimuli in Genetically Obese (Bombesin Receptor Subtype-3–Deficient) Mice , 1999, Physiology & Behavior.

[199]  A. Schally,et al.  Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors. , 1999, European journal of endocrinology.

[200]  R. Jensen,et al.  Pharmacology and cell biology of the bombesin receptor subtype 4 (BB4-R). , 1999, Biochemistry.

[201]  R. Jensen,et al.  The Bombesin Receptor Subtypes Have Distinct G Protein Specificities* , 1999, The Journal of Biological Chemistry.

[202]  R. Benya,et al.  Aberrant expression of gastrin-releasing peptide and its receptor by well-differentiated colon cancers in humans. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[203]  J. Fehrentz,et al.  Syntheses and biological activities of potent bombesin receptor antagonists. , 1999, The journal of peptide research : official journal of the American Peptide Society.

[204]  J C Reubi,et al.  Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. , 1999, Cancer research.

[205]  R. Benya,et al.  Characterization of gastrin-releasing peptide receptors aberrantly expressed by non-antral gastric adenocarcinomas , 1999, Peptides.

[206]  H. Ogura,et al.  Functional Properties of Two Bombesin-Like Peptide Receptors Revealed by the Analysis of Mice Lacking Neuromedin B Receptor , 1999, The Journal of Neuroscience.

[207]  T. Moody,et al.  Bombesin activates MAP kinase in non-small cell lung cancer cells , 1999, Peptides.

[208]  E. Vizi,et al.  Role of Different Bombesin Receptor Subtypes Mediating Contractile Activity in Cat Upper Gastrointestinal Tract , 1998, Peptides.

[209]  J. Fehrentz,et al.  Comparative Study of In Vitro and In Vivo Activities of Bombesin Pseudopeptide Analogs Modified on the C-Terminal Dipeptide Fragment , 1998, Peptides.

[210]  E. Rozengurt Signal transduction pathways in the mitogenic response to G protein–coupled neuropeptide receptor agonists , 1998, Journal of cellular physiology.

[211]  A. Schonbrunn,et al.  Role of receptor and protein kinase C activation in the internalization of the gastrin-releasing peptide receptor. , 1998, Molecular pharmacology.

[212]  J. Chayvialle,et al.  Effects of neurotransmitters, gut hormones, and inflammatory mediators on mucus discharge in rat colon. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[213]  R. Jensen,et al.  Pharmacology and intracellular signaling mechanisms of the native human orphan receptor BRS-3 in lung cancer cells. , 1998, The Journal of pharmacology and experimental therapeutics.

[214]  R. A. Lewthwaite,et al.  PD 176252--the first high affinity non-peptide gastrin-releasing peptide (BB2) receptor antagonist. , 1998, Bioorganic & medicinal chemistry letters.

[215]  B. Yoder,et al.  Bombesin-like peptide mediates lung injury in a baboon model of bronchopulmonary dysplasia. , 1998, The Journal of clinical investigation.

[216]  A. Schally,et al.  Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[217]  Mark Akeson,et al.  Four Amino Acid Residues Are Critical for High Affinity Binding of Neuromedin B to the Neuromedin B Receptor* , 1998, The Journal of Biological Chemistry.

[218]  O. Ziv,et al.  Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues. , 1998, Journal of medicinal chemistry.

[219]  M. Takeyama,et al.  Growth stimulation of normal melanocytes and nevocellular nevus cells by gastrin releasing peptide (GRP). , 1998, Journal of dermatological science.

[220]  J. Battey,et al.  Ability of Various Bombesin Receptor Agonists and Antagonists to Alter Intracellular Signaling of the Human Orphan Receptor BRS-3* , 1998, The Journal of Biological Chemistry.

[221]  R. Jensen,et al.  Structure and chromosomal localization of the mouse bombesin receptor subtype 3 gene. , 1998, Gene.

[222]  R. Jensen,et al.  Neuromedin B activates phospholipase D through both PKC-dependent and PKC-independent mechanisms. , 1998, Biochimica et biophysica acta.

[223]  P. Szekeres,et al.  The relationship between agonist intrinsic activity and the rate of endocytosis of muscarinic receptors in a human neuroblastoma cell line. , 1998, Molecular pharmacology.

[224]  R. Jensen,et al.  Loss of bombesin-induced feeding suppression in gastrin-releasing peptide receptor-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[225]  A. Schally,et al.  Inhibition of the growth of caki‐I human renal adenocarcinoma in Vivo by luteinizing hormone‐releasing hormone antagonist cetrorelix, somatostatin analog RC‐160, and bombesin antagonist RC‐3940‐II , 1998, Cancer.

[226]  H. Nishino,et al.  Mammalian bombesin receptors are coupled to multiple signal transduction pathways in pancreatic acini. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[227]  R. Jensen,et al.  Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes. , 1998, European journal of pharmacology.

[228]  E. Duzic,et al.  [d-Arg1,d-Phe5,d-Trp7,9,Leu11]Substance P Acts as a Biased Agonist toward Neuropeptide and Chemokine Receptors* , 1998, The Journal of Biological Chemistry.

[229]  R. Benya,et al.  Location and Characterization of the Human GRP Receptor Expressed by Gastrointestinal Epithelial Cells , 1997, Peptides.

[230]  R. Jensen,et al.  Neuromedin B receptor activation causes tyrosine phosphorylation of p125FAK by a phospholipase C independent mechanism which requires p21rho and integrity of the actin cytoskeleton. , 1997, Biochemistry.

[231]  H. Ogura,et al.  Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity , 1997, Nature.

[232]  R. Jensen,et al.  Discovery of a High Affinity Radioligand for the Human Orphan Receptor, Bombesin Receptor Subtype 3, Which Demonstrates That It Has a Unique Pharmacology Compared with Other Mammalian Bombesin Receptors* , 1997, The Journal of Biological Chemistry.

[233]  H. Ogura,et al.  Generation and characterization of mice lacking gastrin-releasing peptide receptor. , 1997, Biochemical and biophysical research communications.

[234]  F. Flynn Bombesin Receptor Antagonists Block the Effects of Exogenous Bombesin but Not of Nutrients on Food Intake , 1997, Physiology & Behavior.

[235]  L. Slice,et al.  Bombesin-induced gastrin release from canine G cells is stimulated by Ca2+ but not by protein kinase C, and is enhanced by disruption of rho/cytoskeletal pathways. , 1997, The Journal of clinical investigation.

[236]  J. Siegfried,et al.  Expression of mRNA for gastrin-releasing peptide receptor by human bronchial epithelial cells. Association with prolonged tobacco exposure and responsiveness to bombesin-like peptides. , 1997, American journal of respiratory and critical care medicine.

[237]  P. Boden,et al.  Construction of chimeric human bombesin receptors to identify neuromedin B and gastrin-releasing peptide receptor binding sites. , 1997, Biochemical Society transactions.

[238]  H. Ohki‐Hamazaki,et al.  Cloning and expression of the neuromedin B receptor and the third subtype of bombesin receptor genes in the mouse , 1997, Brain Research.

[239]  R. Jensen,et al.  Identification of Four Amino Acids in the Gastrin-releasing Peptide Receptor That Are Required for High Affinity Agonist Binding* , 1997, The Journal of Biological Chemistry.

[240]  J. Mulshine,et al.  Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer. , 1997, Chest.

[241]  M. Sharif,et al.  Functional expression of bombesin receptor in most adult and pediatric human glioblastoma cell lines; role in mitogenesis and in stimulating the mitogen-activated protein kinase pathway , 1997, Molecular and Cellular Endocrinology.

[242]  M. Sporn Growth factors and cytokines in health and disease , 1997 .

[243]  R. Jensen,et al.  The gastrin-releasing peptide receptor is differentially coupled to adenylate cyclase and phospholipase C in different tissues. , 1997, Biochimica et biophysica acta.

[244]  R. Jensen,et al.  Effect of gastrin-releasing peptide receptor number on receptor affinity, coupling, degradation, and modulation. , 1997, Molecular pharmacology.

[245]  N. Jones,et al.  Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells , 1997, Oncogene.

[246]  R. Jordan,et al.  PD 165929 - The First High Affinity Non-Peptide Neuromedin-B (NMB) Receptor Selective Antagonist. , 1997 .

[247]  D. Coy,et al.  Role of vagal fibers and bombesin/gastrin-releasing peptide-neurons in distention-induced gastrin release in rats , 1997, Regulatory Peptides.

[248]  J. Polak,et al.  Pituitary neuromedin B content in experimental fasting and diabetes mellitus and correlation with thyrotropin secretion. , 1997, Metabolism: clinical and experimental.

[249]  R. Jensen,et al.  Characterization of bombesin binding sites in the rat stomach. , 1997, European journal of pharmacology.

[250]  T. Moody,et al.  BW1023U90: A new GRP receptor antagonist for small-cell lung cancer cells , 1996, Peptides.

[251]  T. Seufferlein,et al.  Dissociation of mitogen-activated protein kinase activation from p125 focal adhesion kinase tyrosine phosphorylation in Swiss 3T3 cells stimulated by bombesin, lysophosphatidic acid, and platelet-derived growth factor. , 1996, Molecular biology of the cell.

[252]  R. Jordan,et al.  PD 165929 — the first high affinity non-peptide neuromedin-B (NMB) receptor selective antagonist , 1996 .

[253]  R. Feldman,et al.  Discovery of high affinity bombesin receptor subtype 3 agonists. , 1996, Molecular pharmacology.

[254]  M. Kane,et al.  Clinical correlates of bombesin-like peptide receptor subtype expression in human lung cancer cells. , 1996, Lung cancer.

[255]  E. Rozengurt,et al.  Bombesin, Bradykinin, Vasopressin, and Phorbol Esters Rapidly and Transiently Activate Src Family Tyrosine Kinases in Swiss 3T3 Cells , 1996, The Journal of Biological Chemistry.

[256]  Y. Wang,et al.  Agonist binding and protein kinase C activation stimulate phosphorylation of the gastrin-releasing peptide receptor at distinct sites. , 1996, Molecular pharmacology.

[257]  L. Gozzini,et al.  Bombesin receptor antagonists. , 1996, Critical reviews in oncology/hematology.

[258]  G. Nussdorfer,et al.  The role of neuromedin B in the regulation of rat pituitary-adrenocortical function. , 1996, Histology and histopathology.

[259]  T. Seufferlein,et al.  Reduced Requirement of Mitogen-activated Protein Kinase (MAPK) Activity for Entry into the S Phase of the Cell Cycle in Swiss 3T3 Fibroblasts Stimulated by Bombesin and Insulin* , 1996, The Journal of Biological Chemistry.

[260]  J. Fehrentz,et al.  JMV641: A potent bombesin receptor antagonist that inhibits Swiss 3T3 cell proliferation , 1996, Regulatory Peptides.

[261]  T. Moran,et al.  Receptor subtype mediation of feeding suppression by bombesin-like peptides , 1996, Pharmacology Biochemistry and Behavior.

[262]  D. Venzon,et al.  Somatostatin Receptor Scintigraphy: Its Sensitivity Compared with That of Other Imaging Methods in Detecting Primary and Metastatic Gastrinomas: A Prospective Study , 1996, Annals of Internal Medicine.

[263]  J. Taylor,et al.  Hindbrain GRP receptor blockade antagonizes feeding suppression by peripherally administered GRP. , 1996, The American journal of physiology.

[264]  J. Taylor,et al.  Pharmacological profiles of two bombesin analogues in cells transfected with human neuromedin B receptors. , 1996, European journal of pharmacology.

[265]  J. Parsons,et al.  p130Cas, a Substrate Associated with v-Src and v-Crk, Localizes to Focal Adhesions and Binds to Focal Adhesion Kinase* , 1996, The Journal of Biological Chemistry.

[266]  J. Polak,et al.  Role of Neuromedin B in the In Vitro Thyrotropin Release in Response to Thyrotropin-Releasing Hormone from Anterior Pituitaries of Eu-, Hypo-, and Hyperthyroid Rats , 1996, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[267]  B. Gibson,et al.  There Are Three Distinct Forms of Bombesin , 1996, The Journal of Biological Chemistry.

[268]  S. O’Grady,et al.  Regulation of colonic ion transport by GRP. I. GRP stimulates transepithelial K and Na secretion. , 1996, The American journal of physiology.

[269]  S. Gregersen,et al.  Studies on the Mechanisms by Which Gastrin Releasing Peptide Potentiates Glucose‐Induced Insulin Secretion from Mouse Islets , 1996, Pancreas.

[270]  T. Moody,et al.  Neuromedin B stimulates arachidonic acid release, c-fos gene expression, and the growth of C6 glioma cells , 1995, Peptides.

[271]  R. Jensen,et al.  Comparison of the peptide structural requirements for high affinity interaction with bombesin receptors. , 1995, European journal of pharmacology.

[272]  E. Rozengurt,et al.  Mitogenic signaling by transfected neuromedin B receptors in Rat-1 cells. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[273]  A. Schally,et al.  Antagonists of bombesin/gastrin‐releasing peptide inhibit growth of SW‐1990 human pancreatic adenocarcinoma and production of cyclic AMP , 1995, International journal of cancer.

[274]  R. Jensen,et al.  Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes. , 1995, The Journal of pharmacology and experimental therapeutics.

[275]  C. Van Renterghem,et al.  Properties and functions of a neuromedin-B-preferring bombesin receptor in brain microvascular endothelial cells. , 1995, European journal of biochemistry.

[276]  R. T. Jensen,et al.  Mammalian bombesin receptors , 1995, Medicinal research reviews.

[277]  T. Fukai,et al.  Non-peptide bombesin receptor antagonists, kuwanon G and H, isolated from mulberry. , 1995, Biochemical and biophysical research communications.

[278]  K. Detjen,et al.  Carboxyl-terminal Domains Determine Internalization and Recycling Characteristics of Bombesin Receptor Chimeras (*) , 1995, The Journal of Biological Chemistry.

[279]  C. Logsdon,et al.  Influence of Second and Third Cytoplasmic Loops on Binding, Internalization, and Coupling of Chimeric Bombesin/m3 Muscarinic Receptors (*) , 1995, The Journal of Biological Chemistry.

[280]  Ian Foracs Physiology of the Gastrointestinal Tract (3rd ed) , 1995 .

[281]  B. Evers,et al.  Role of Bombesin on Gut Mucosal Growth , 1995, Annals of surgery.

[282]  R. Jensen,et al.  Characterization of gastrin-releasing peptide receptor expressed in Sf9 insect cells by baculovirus. , 1995, Biochemistry.

[283]  E. Spindel,et al.  Cloning of a receptor for amphibian [Phe13]bombesin distinct from the receptor for gastrin-releasing peptide: identification of a fourth bombesin receptor subtype (BB4). , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[284]  J. Primrose,et al.  High-affinity binding sites for gastrin-releasing peptide on human colorectal cancer tissue but not uninvolved mucosa. , 1995, British Journal of Cancer.

[285]  J. Battey,et al.  The Gastrin-releasing Peptide Receptor Is Rapidly Phosphorylated by a Kinase Other Than Protein Kinase C After Exposure to Agonist (*) , 1995, The Journal of Biological Chemistry.

[286]  R. Feldman,et al.  Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs. , 1995, Molecular pharmacology.

[287]  David C. orwell The ‘peptoid’ approach to the design of non-peptide, small molecule agonists and antagonists of neuropeptides , 1995 .

[288]  D. Payan,et al.  Direct Observation of Endocytosis of Gastrin Releasing Peptide and Its Receptor (*) , 1995, The Journal of Biological Chemistry.

[289]  D. Coy,et al.  Fourth ventricular injection of the bombesin receptor antagonist [d-phe6]bombesin(6–13)methyl ester, but not BW2258U89, increases food intake in rats , 1995, Pharmacology Biochemistry and Behavior.

[290]  R. Jensen,et al.  Chronic Desensitization and Down-regulation of the Gastrin-releasing Peptide Receptor Are Mediated by a Protein Kinase C-dependent Mechanism (*) , 1995, The Journal of Biological Chemistry.

[291]  T. Moody,et al.  BW2258U89: a GRP receptor antagonist which inhibits small cell lung cancer growth. , 1995, Life sciences.

[292]  A. Schally,et al.  Potent bombesin antagonists with C-terminal Leu-psi(CH2-N)-Tac-NH2 or its derivatives. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[293]  J. Taylor,et al.  Blockade of feeding inhibition by neuromedin B using a selective receptor antagonist. , 1994, European journal of pharmacology.

[294]  R. Jensen,et al.  Glycosylation of bombesin receptors: characterization, effect on binding, and G-protein coupling. , 1994, Biochemistry.

[295]  E. Spindel,et al.  A rhesus monkey model to characterize the role of gastrin-releasing peptide (GRP) in lung development. Evidence for stimulation of airway growth. , 1994, The Journal of clinical investigation.

[296]  A. Schally,et al.  Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors , 1994, Journal of Cancer Research and Clinical Oncology.

[297]  R. Jensen,et al.  Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes. , 1994, Molecular pharmacology.

[298]  L. Slice,et al.  The conserved NPXnY motif present in the gastrin-releasing peptide receptor is not a general sequestration sequence. , 1994, The Journal of biological chemistry.

[299]  T. Reynolds,et al.  Different types of bombesin receptors on neurons in the dorsal raphe nucleus and the rostral hypothalamus in rat brain slices in vitro , 1994, Brain Research.

[300]  H. Parkman,et al.  Pharmacological analysis of receptors for bombesin-related peptides on guinea pig gallbladder smooth muscle , 1994, Regulatory Peptides.

[301]  R. Jensen,et al.  Gastrin-releasing peptide receptor-induced internalization, down-regulation, desensitization, and growth: possible role for cyclic AMP. , 1994, Molecular pharmacology.

[302]  J. Battey,et al.  Neuromedin B receptor, expressed in Xenopus laevis oocytes, selectively couples to Gαq and not Gα11 , 1994 .

[303]  A. Schally,et al.  Characterization of high‐affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC‐3 and DU‐145: Internalization of receptor bound 125I‐(Tyr4) bombesin by tumor cells , 1994, The Prostate.

[304]  T. Kirkham,et al.  A novel bombesin receptor antagonist selectively blocks the satiety action of peripherally administered bombesin , 1994, Pharmacology Biochemistry and Behavior.

[305]  J. Siegfried,et al.  Expression of mRNA for three bombesin receptor subtypes in human bronchial epithelial cells. , 1994, American journal of respiratory cell and molecular biology.

[306]  R. Jensen,et al.  Desensitization of neuromedin B receptors (NMB-R) on native and NMB-R-transfected cells involves down-regulation and internalization. , 1994, The Journal of biological chemistry.

[307]  K. Grzeschik,et al.  Organization and chromosomal localization of the gene for the human bombesin receptor subtype expressed in pregnant uterus , 1994, FEBS letters.

[308]  W. Sadee,et al.  Overlapping multi-site domains of the muscarinic cholinergic Hm1 receptor involved in signal transduction and sequestration. , 1994, The Journal of biological chemistry.

[309]  R. Plevin,et al.  Rapid desensitization and resensitization of bombesin-stimulated phospholipase D activity in Swiss 3T3 cells. , 1994, The Biochemical journal.

[310]  A. Schonbrunn,et al.  Bombesin receptors in a human duodenal tumor cell line: binding properties and function. , 1994, Cancer research.

[311]  S. Guard,et al.  Rational design of high affinity tachykinin NK2 receptor antagonists. , 1994, Bioorganic & medicinal chemistry.

[312]  Á. Hernanz,et al.  Bombesin, gastrin-releasing peptide, and neuromedin C modulate murine lymphocyte proliferation through adherent accessory cells and activate protein kinase C , 1994, Peptides.

[313]  C. Turner Paxillin: A cytoskeletal target for tyrosine kinases , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.

[314]  Á. Hernanz,et al.  Stimulation of natural killer and antibody-dependent cellular cytotoxicity activities in mouse leukocytes by bombesin, gastrin-releasing peptide and neuromedin C: Involvement of cyclic AMP, inositol 1,4,5-trisphosphate and protein kinase C , 1993, Journal of Neuroimmunology.

[315]  W. Sadee,et al.  Hydrophobic amino acid in the i2 loop plays a key role in receptor-G protein coupling. , 1993, The Journal of biological chemistry.

[316]  R. Jensen,et al.  Discovery of a novel class of neuromedin B receptor antagonists, substituted somatostatin analogues. , 1993, Molecular pharmacology.

[317]  R. Jensen,et al.  Serines and threonines in the gastrin-releasing peptide receptor carboxyl terminus mediate internalization. , 1993, The Journal of biological chemistry.

[318]  M. Bouzyk,et al.  Homologous desensitization of bombesin‐induced increases in intracellular Ca2+ in quiescent swiss 3T3 cells involves a protein kinase C‐independent mechanism , 1993, Journal of cellular physiology.

[319]  J. Benovic,et al.  Mechanism of beta-adrenergic receptor kinase activation by G proteins. , 1993, The Journal of biological chemistry.

[320]  R. Jensen,et al.  The fifth transmembrane segment of the neuromedin B receptor is critical for high affinity neuromedin B binding. , 1993, The Journal of biological chemistry.

[321]  Á. Valverde,et al.  Bombesin stimulation of p125 focal adhesion kinase tyrosine phosphorylation. Role of protein kinase C, Ca2+ mobilization, and the actin cytoskeleton. , 1993, The Journal of biological chemistry.

[322]  G. Maslen,et al.  Comparative mapping of the Grpr locus on the X chromosomes of man and mouse. , 1993, Genomics.

[323]  E. Sausville,et al.  Neuromedin-B receptor transfected BALB/3T3 cells: signal transduction and effects of ectopic receptor expression on cell growth , 1993, Regulatory Peptides.

[324]  J. Siegfried,et al.  Effects of bombesin and gastrin‐releasing peptide on human bronchial epithelial cells from a series of donors: Individual variation and modulation by bombesin analogs , 1993, The Anatomical record.

[325]  R. Jensen,et al.  Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes. , 1993, Molecular pharmacology.

[326]  R. Jensen,et al.  Bombesin receptor antagonists differentiate receptor subtypes in rat brain. , 1993, European journal of pharmacology.

[327]  E. Sausville,et al.  BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells. , 1993, The Journal of biological chemistry.

[328]  D. Rees,et al.  Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and "mixed" CCK-A/CCK-B antagonists. , 1993, Journal of medicinal chemistry.

[329]  B. Stockstill,et al.  Development of potent gastrin-releasing peptide antagonists having a D-Pro-psi(CH2NH)-Phe-NH2 C terminus. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[330]  H. Verspaget,et al.  Neuroenteric peptides affect natural killer activity by intestinal lamina propria mononuclear cells , 1993, Journal of Neuroimmunology.

[331]  P. Mantyh,et al.  Bombesin/GRP-preferring and neuromedin B-preferring receptors in the rat urogenital system , 1993, Neuropeptides.

[332]  R. Jensen,et al.  Ligand binding, internalization, degradation and regulation by guanine nucleotides of bombesin receptor subtypes: a comparative study. , 1993, Biochimica et biophysica acta.

[333]  R. Jensen,et al.  Neuromedin B receptors retain functional expression when transfected into BALB 3T3 fibroblasts: analysis of binding, kinetics, stoichiometry, modulation by guanine nucleotide-binding proteins, and signal transduction and comparison with natively expressed receptors. , 1992, Molecular pharmacology.

[334]  R. Jensen,et al.  Distinct distribution of two bombesin receptor subtypes in the rat central nervous system , 1992, Brain Research.

[335]  D. Metz,et al.  Thapsigargin defines the roles of cellular calcium in secretagogue-stimulated enzyme secretion from pancreatic acini. , 1992, The Journal of biological chemistry.

[336]  B. Stockstill,et al.  Conveyance of partial agonism/antagonism to bombesin/gastrin-releasing peptide analogues on Swiss 3T3 cells by a carboxyl-terminal leucine insertion. , 1992, The Journal of biological chemistry.

[337]  R. Jensen,et al.  Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines. , 1992, The Journal of pharmacology and experimental therapeutics.

[338]  R. Jensen,et al.  Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides. , 1992, The Biochemical journal.

[339]  F. Fahrenholz,et al.  Molecular cloning of a new bombesin receptor subtype expressed in uterus during pregnancy. , 1992, European journal of biochemistry.

[340]  J. Smyth,et al.  Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo. , 1992, Cancer research.

[341]  D. Coy,et al.  Identification and initial characterization of a putative neuromedin B-type receptor from rat urinary bladder membranes. , 1992, European journal of pharmacology.

[342]  C. Maggi,et al.  Effect of [D-Phe6] bombesin (6-13) methylester, a bombesin receptor antagonist, towards bombesin-induced contractions in the guinea-pig and rat isolated urinary bladder. , 1992, Journal of autonomic pharmacology.

[343]  J. Leban,et al.  A novel bombesin receptor antagonist (2258U89), potently inhibits bombesin evoked release of gastrointestinal hormones from rats and dogs, in vitro and in vivo , 1992, Regulatory Peptides.

[344]  R. Jensen,et al.  Development of a potent bombesin receptor antagonist with prolonged in vivo inhibitory activity on bombesin-stimulated amylase and protein release in the rat , 1992, Peptides.

[345]  D. Hill,et al.  Mitogenic action of gastrin-releasing polypeptide on isolated epiphyseal growth plate chondrocytes from the ovine fetus. , 1992, Endocrinology.

[346]  D. Withers,et al.  Evidence for neuromedin-B synthesis in the rat anterior pituitary gland. , 1992, Endocrinology.

[347]  J. Polak,et al.  Role of neuromedin B in control of the release of thyrotropin in hypothyroid and hyperthyroid rats. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[348]  M. Wakelam,et al.  Bombesin stimulates the rapid activation of phospholipase A2-catalyzed phosphatidylcholine hydrolysis in Swiss 3T3 cells. , 1992, The Journal of biological chemistry.

[349]  A. Gazdar,et al.  Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. , 1992, Cancer research.

[350]  A. Schally,et al.  Pseudononapeptide bombesin antagonists containing C-terminal Trp or Tpi , 1992, Peptides.

[351]  S. Narayan,et al.  A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[352]  J. Battey,et al.  Two distinct receptor subtypes for mammalian bombesin-like peptides , 1991, Trends in Neurosciences.

[353]  S. Cook,et al.  The regulation of phospholipase D activity and its role in sn-1,2-diradylglycerol formation in bombesin- and phorbol 12-myristate 13-acetate-stimulated Swiss 3T3 cells. , 1991, The Biochemical journal.

[354]  A. Schally,et al.  Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095). , 1991, Cancer research.

[355]  H. Yamamoto,et al.  Bombesin and bradykinin increase inositol phosphates and cytosolic free Ca2+, and stimulate DNA synthesis in human endometrial stromal cells. , 1991, The Journal of endocrinology.

[356]  E. Sausville,et al.  Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells. , 1991, The Journal of biological chemistry.

[357]  R. Jensen,et al.  Covalently cyclized agonist and antagonist analogues of bombesin and related peptides. , 1991, The Journal of biological chemistry.

[358]  D. Coy,et al.  Comparison of prolonged in vivo inhibitory activity of several potent bombesin (BN) antagonists on BN-stimulated amylase secretion in the rat , 1991, Peptides.

[359]  B. Göke,et al.  Binding, internalization, and processing of bombesin by rat pancreatic acini. , 1991, The American journal of physiology.

[360]  D. Heimbrook,et al.  Gastrin releasing peptide antagonists with improved potency and stability. , 1991, Journal of medicinal chemistry.

[361]  T. Matozaki,et al.  Intracellular mediators of bombesin action on rat pancreatic acinar cells. , 1991, The American journal of physiology.

[362]  M. De la Fuente,et al.  Modulation of phagocytic function in murine peritoneal macrophages by bombesin, gastrin-releasing peptide and neuromedin C. , 1991, Immunology.

[363]  R. Jensen,et al.  Different receptors mediate the action of bombesin-related peptides on gastric smooth muscle cells. , 1991, The American journal of physiology.

[364]  D. Coy,et al.  Effects of potent bombesin antagonist on exocrine pancreatic secretion in rats , 1991, Peptides.

[365]  R. Jensen,et al.  cDNA cloning, characterization, and brain region-specific expression of a neuromedin-B-preferring bombesin receptor , 1991, Neuron.

[366]  C. Denef,et al.  Effect of the bombesin receptor blockers [Leu13,ψCH2NH-Leu14]bombesin and N-pivaloyl GRP(20–25) alkylamide (L 686,095-001C002) on basal and neuromedin C-stimulated PRL and GH release in pituitary cell aggregates , 1991, Peptides.

[367]  K. Patel,et al.  Modulation of inositol lipid hydrolysis in human breast cancer cells by two classes of bombesin antagonist. , 1991, Journal of molecular endocrinology.

[368]  R. Feldman,et al.  Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[369]  R. Jensen,et al.  Reduced peptide bond pseudopeptide analogues of secretin. A new class of secretin receptor antagonists. , 1991, The Journal of biological chemistry.

[370]  P. McHugh,et al.  Receptor heterogeneity for bombesin-like peptides in the rat central nervous system , 1990, Brain Research.

[371]  P. Brehm,et al.  Cloning and functional characterization of a complementary DNA encoding the murine fibroblast bombesin/gastrin-releasing peptide receptor. , 1990, Molecular endocrinology.

[372]  L. Wang,et al.  Short chain bombesin pseudopeptides with potent bombesin receptor antagonist activity in rat and guinea pig pancreatic acinar cells. , 1990, European journal of pharmacology.

[373]  R. Jensen,et al.  Characterization of the bombesin receptor on mouse pancreatic acini by chemical cross-linking , 1990, Peptides.

[374]  R. Feldman,et al.  Purification and characterization of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells. , 1990, The Journal of biological chemistry.

[375]  R. Jensen,et al.  des-Met carboxyl-terminally modified analogues of bombesin function as potent bombesin receptor antagonists, partial agonists, or agonists. , 1990, The Journal of biological chemistry.

[376]  R. Jensen,et al.  Potent bombesin receptor antagonists distinguish receptor subtypes. , 1990, The American journal of physiology.

[377]  E. Wada,et al.  Neuromedin B and gastrin-releasing peptide mRNAs are differentially distributed in the rat nervous system , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[378]  J. Millar,et al.  Chronic desensitization to bombesin by progressive down-regulation of bombesin receptors in Swiss 3T3 cells. Distinction from acute desensitization. , 1990, The Journal of biological chemistry.

[379]  M. Sheppard,et al.  Expression of gastrin‐releasing peptide (human bombesin) gene in large cell undifferentiated carcinoma of the lung , 1990, The Journal of pathology.

[380]  S. Swope,et al.  Desensitization of islet cells to bombesin involves both receptor down-modulation and inhibition of receptor function. , 1990, Molecular pharmacology.

[381]  M. Sporn,et al.  Peptide Growth Factors and Their Receptors I , 1990, Handbook of Experimental Pharmacology.

[382]  K. Hermansen,et al.  Gastrin releasing peptide stimulates the secretion of insulin, but not that of glucagon or somatostatin, from the isolated perfused dog pancreas. , 1990, Acta physiologica Scandinavica.

[383]  R. Jensen,et al.  Desmethionine alkylamide bombesin analogues: a new class of bombesin receptor antagonists with potent antisecretory activity in pancreatic acini and antimitotic activity in Swiss 3T3 cells. , 1990, Biochemistry.

[384]  R. Jensen,et al.  Reduced peptide bond pseudopeptide analogues of substance P. A new class of substance P receptor antagonists with enhanced specificity. , 1989, The Journal of biological chemistry.

[385]  R. Jensen,et al.  Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity. , 1989, The Journal of biological chemistry.

[386]  D. Heimbrook,et al.  Carboxyl-terminal modification of a gastrin releasing peptide derivative generates potent antagonists. , 1989, The Journal of biological chemistry.

[387]  R. Jensen,et al.  Effect of substitutions in position 12 of bombesin on antagonist activity , 1989, Peptides.

[388]  R. Jensen,et al.  Neuromedin B receptor in esophagus: evidence for subtypes of bombesin receptors. , 1989, The American journal of physiology.

[389]  S. Wank,et al.  Regulation of bombesin receptors on pancreatic acini by cholecystokinin. , 1989, The American journal of physiology.

[390]  K. Dickinson,et al.  Partial agonist activity of the bombesin-receptor antagonist [Leu14-psi-CH2-NH-Leu13]-bombesin in frog peptic cells. , 1988, Biochemical and biophysical research communications.

[391]  E. Rozengurt Bombesin‐Induction of Cell Proliferation in 3T3 Cells , 1988, Annals of the New York Academy of Sciences.

[392]  Eliot R. Spindel,et al.  Report and Recommendations 14 October 1987 , 1988 .

[393]  N. Rhaleb,et al.  Receptors for Neurokinins, Tachykinins, and Bombesin: A Pharmacological Study a , 1988 .

[394]  R. Jensen,et al.  Interaction of Bombesin and Related Peptides with Receptors on Pancreatic Acinar Cells , 1988, Annals of the New York Academy of Sciences.

[395]  I. Hramiak,et al.  The Effect of Gastrin‐Releasing Peptide on the Endocrine Pancreas a , 1988, Annals of the New York Academy of Sciences.

[396]  T. O'donohue,et al.  Localization of Receptors for Bombesin‐like Peptides in the Rat Brain 1 , 1988, Annals of the New York Academy of Sciences.

[397]  V. Erspamer Discovery, Isolation, and Characterization of Bombesin‐like Peptides , 1988 .

[398]  P. Panula,et al.  Localization and Development of Bombesin/GRP‐like Immunoreactivity in the Rat Central Nervous System a , 1988, Annals of the New York Academy of Sciences.

[399]  J. Gibbs,et al.  The Actions of Bombesin‐like Peptides on Food Intake a , 1988, Annals of the New York Academy of Sciences.

[400]  E. Rozengurt,et al.  Characterization of a bombesin receptor on Swiss mouse 3T3 cells by affinity cross‐linking , 1988, Journal of cellular biochemistry.

[401]  E. Sausville,et al.  A novel bombesin receptor antagonist inhibits autocrine signals in a small cell lung carcinoma cell line. , 1988, Biochemical and biophysical research communications.

[402]  J. Millar,et al.  Bombesin enhancement of cAMP accumulation in swiss 3T3 cells: Evidence of a dual mechanism of action , 1988, Journal of cellular physiology.

[403]  R. Jensen,et al.  An analogue of substance P with broad receptor antagonist activity. , 1988, Biochimica et biophysica acta.

[404]  T. Matozaki,et al.  Somatostatin receptors on rat cerebrocortical membranes. Structural characterization of somatostatin-14 and somatostatin-28 receptors and comparison with pancreatic type receptors. , 1988, The Journal of biological chemistry.

[405]  P. Woll,et al.  Bombesin and bombesin antagonists: studies in Swiss 3T3 cells and human small cell lung cancer. , 1988, British Journal of Cancer.

[406]  R. Jensen,et al.  Characterization of ability of various substance P antagonists to inhibit action of bombesin. , 1988, The American journal of physiology.

[407]  V. Garsky,et al.  Minimal Ligand Analysis of Gastrin‐Releasing Peptide: Receptor Binding and Mitogenesis , 1988, The Journal of biological chemistry.

[408]  A. N. Corps,et al.  Characterization of the high-affinity receptors on Swiss 3T3 cells which mediate the binding, internalization and degradation of the mitogenic peptide bombesin. , 1988, The Biochemical journal.

[409]  C. Severini,et al.  Parallel bioassay of 27 bombesin-like peptides on 9 smooth muscle preparations. Structure-activity relationships and bombesin receptor subtypes , 1988, Regulatory Peptides.

[410]  R. Jensen,et al.  Probing peptide backbone function in bombesin. A reduced peptide bond analogue with potent and specific receptor antagonist activity. , 1988, The Journal of biological chemistry.

[411]  M. Nakamura,et al.  Autoradiographic demonstration of gastrin-releasing peptide-binding sites in the rat gastric mucosa. , 1988, Gastroenterology.

[412]  P. Woll,et al.  [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[413]  K. Kawai,et al.  Effects of neuromedin B, gastrin-releasing peptide-10 and their fragment peptides on secretion of gastrointestinal and pancreatic hormones in dogs. , 1988, Acta endocrinologica.

[414]  K. Gautvik,et al.  Bombesin stimulates prolactin secretion from cultured rat pituitary tumour cells (GH4C1) via activation of phospholipase C , 1987, Regulatory Peptides.

[415]  S. Swope,et al.  Characterization of ligand binding and processing by bombesin receptors in an insulin-secreting cell line. , 1987, The Biochemical journal.

[416]  T. Moody,et al.  Identification of the bombesin-receptor on murine and human cells by cross-linking experiments , 1987, Regulatory Peptides.

[417]  E. Rozengurt,et al.  Internalization and degradation of peptides of the bombesin family in Swiss 3T3 cells occurs without ligand‐induced receptor down‐regulation. , 1987, The EMBO journal.

[418]  D. Coy,et al.  Solid-phase synthesis and biological properties of psi [CH2NH] pseudopeptide analogues of a highly potent somatostatin octapeptide. , 1987, Journal of medicinal chemistry.

[419]  M. Collins,et al.  Protein kinase C activation enhances cAMP accumulation in Swiss 3T3 cells: inhibition by pertussis toxin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[420]  A. Giraud,et al.  Bombesin stimulation of gastrin release from canine gastrin cells in primary culture. , 1987, The American journal of physiology.

[421]  R. Jensen,et al.  [D-Phe12]bombesin analogues: a new class of bombesin receptor antagonists. , 1987, The American journal of physiology.

[422]  B. Ahrén,et al.  Gastrin Releasing Peptide (GRP): Effects on basal and stimulated insulin and glucagon secretion in the mouse , 1987, Peptides.

[423]  G. Greeley,et al.  Effect of Bombesin and Gastrin-Releasing Peptide on the Release of Gastric Inhibitory Polypeptide and Insulin in Rats 1 , 1986, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[424]  T. O'donohue,et al.  Neuromedin B-like peptides in rat brain: Biochemical characterization, mechanism of release and localization in synaptosomes , 1986, Peptides.

[425]  J. Bali,et al.  Synthesis and biological activities of some pseudo-peptide analogues of tetragastrin: the importance of the peptide backbone. , 1985, Journal of medicinal chemistry.

[426]  N. Minamino,et al.  Neuromedin B-32 and B-30: two "big" neuromedin B identified in porcine brain and spinal cord. , 1985, Biochemical and biophysical research communications.

[427]  J. Minna,et al.  High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer. , 1985, Life sciences.

[428]  N. Minamino,et al.  Neuromedin B is a major bombesin-like peptide in rat brain: regional distribution of neuromedin B and neuromedin C in rat brain, pituitary and spinal cord. , 1984, Biochemical and biophysical research communications.

[429]  J. Willey,et al.  Bombesin and the C-terminal tetradecapeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cells. , 1984, Experimental cell research.

[430]  R. Jensen,et al.  A synthetic peptide that is a bombesin receptor antagonist , 1984, Nature.

[431]  N. Minamino,et al.  Neuromedin C: a bombesin-like peptide identified in porcine spinal cord. , 1984, Biochemical and biophysical research communications.

[432]  F. Sundler,et al.  Gastrin-releasing peptide (GRP) in neurones of the mammalian gut , 1983, Regulatory Peptides.

[433]  L. Rees,et al.  Distribution and characterisation of immunoreactive somatostatin in human gastrointestinal tract , 1983, Regulatory Peptides.

[434]  N. Minamino,et al.  Neuromedin B: a novel bombesin-like peptide identified in porcine spinal cord. , 1983, Biochemical and biophysical research communications.

[435]  E. Rozengurt,et al.  Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[436]  T. Adrian,et al.  Dose-response comparisons of canine plasma gastroenteropancreatic hormone responses to bombesin and the porcine gastrin-releasing peptide (GRP) , 1983, Regulatory Peptides.

[437]  R. Jensen,et al.  Mechanism of [Tyr4]bombesin-induced desensitization in dispersed acini from guinea pig pancreas. , 1982, The Journal of biological chemistry.

[438]  P. Panula,et al.  Neuronal location of the bombesin-like immunoreactivity in the central nervous system of the rat , 1982, Regulatory Peptides.

[439]  T. Adrian,et al.  Bombesin: action on gut hormones and calcium in man. , 1982, The Journal of clinical endocrinology and metabolism.

[440]  G. Mazzanti,et al.  Relative potencies of porcine bombesin‐like heptacosapeptide (PB‐27), amphibian bombesin (B‐14) and litorin, and bombesin C‐terminal nonapeptide (B‐9) on in vitro and in vivo smooth muscle preparations , 1982, The Journal of pharmacy and pharmacology.

[441]  J. Rivier,et al.  Bombesin analogs: Effects on thermoregulation and glucose metabolism , 1981, Peptides.

[442]  P. Newberne,et al.  Working Group IV: lipids and the immune system. Report and recommendations. , 1981, Cancer research.

[443]  P. D. Webster,et al.  Pancreatic exocrine secretion. , 1981, Clinics in gastroenterology.

[444]  V. Mutt,et al.  A qualitative comparison of canine plasma gastroenteropancreatic hormone responses to bombesin and the porcine gastrin-releasing peptide (GRP) , 1981, Regulatory Peptides.

[445]  Jensen Rt,et al.  Identification and characterization of receptors for secretagogues on pancreatic acinar cells. , 1981 .

[446]  J. Walsh,et al.  Stimulation of canine pancreatic polypeptide, gastrin, and gastric acid secretion by ranatensin, litorin, bombesin nonapeptide and substance p , 1981, Regulatory Peptides.

[447]  R. Jensen,et al.  Bombesin-induced desensitization of enzyme secretion in dispersed acini from guinea pig pancreas. , 1980, The American journal of physiology.

[448]  E. Rolls,et al.  Bombesin suppresses feeding in rats , 1979, Nature.

[449]  M. Nirenberg,et al.  Muscarinic acetylcholine receptor regulation by accelerated rate of receptor loss. , 1979, Biochemical and biophysical research communications.

[450]  G Nilsson,et al.  Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. , 1979, Biochemical and biophysical research communications.

[451]  C. Pert,et al.  Interaction of bombesin and litorin with specific membrane receptors on pancreatic acinar cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[452]  J. Rivier,et al.  Bomebesin: specific binding to rat brain membranes. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[453]  J. Rivier,et al.  Bombesin, bombesin analogues, and related peptides: effects on thermoregulation. , 1978, Biochemistry.

[454]  P. de Neef,et al.  In vitro action of bombesin and bombesin-like peptides on amylase secretion, calcium efflux, and adenylate cyclase activity in the rat pancreas: a comparison with other secretagogues. , 1976, The Journal of clinical investigation.

[455]  G. Erspamer,et al.  RELATIVE POTENCY OF BOMBESIN‐LIKE PEPTIDES , 1975, British journal of pharmacology.

[456]  V. Erspamer,et al.  Active polypeptides of the amphibian skin and their synthetic analogues , 1973 .

[457]  V. Erspamer,et al.  Occurrence of bombesin and alytesin in extracts of the skin of three European discoglossid frogs and pharmacological actions of bombesin on extravascular smooth muscle , 1972, British journal of pharmacology.

[458]  V. Erspamer,et al.  Some pharmacological actions of alytesin and bombesin , 1970, The Journal of pharmacy and pharmacology.

[459]  V. Bennett,et al.  Gastrin Releasing Peptide , 2008 .

[460]  E. Krenning,et al.  Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[461]  R. Jensen,et al.  Solubilization and purification of bombesin/gastrin releasing peptide receptors from human cell lines , 2007, Journal of Molecular Neuroscience.

[462]  L. Strauss,et al.  68 Ga-Labeled Bombesin Studies in Patients with Gastrointestinal Stromal Tumors: Comparison with 18 F-FDG , 2007 .

[463]  R. Jensen,et al.  Bombesin/gastrin-releasing peptide receptor antagonists increase the ability of histone deacetylase inhibitors to reduce lung cancer proliferation , 2007, Journal of Molecular Neuroscience.

[464]  F. Forrer,et al.  Neuroendocrine tumors. Peptide receptor radionuclide therapy. , 2007, Best practice & research. Clinical endocrinology & metabolism.

[465]  R. Benya,et al.  Gastrin-releasing peptide mediates its morphogenic properties in human colon cancer by upregulating intracellular adhesion protein-1 (ICAM-1) via focal adhesion kinase. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[466]  G. Baldwin,et al.  Synthesis, expression and biological activity of the prohormone for gastrin releasing peptide (ProGRP). , 2006, Endocrinology.

[467]  R. Jensen,et al.  Bombesin-Related Peptides and Neurotensin: Effects on Cancer Growth/Proliferation and Cellular Signaling in Cancer , 2006 .

[468]  J. Pittet,et al.  Bombesin-like peptides: modulators of inflammation in acute lung injury? , 2006, American journal of respiratory and critical care medicine.

[469]  A. Nunn,et al.  Selective in vitro targeting of GRP and NMB receptors in human tumours with the new bombesin tracer 177Lu-AMBA , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[470]  J. Parry,et al.  MicroPET Imaging of Breast Cancer Using Radiolabeled Bombesin Analogs Targeting the Gastrin-releasing Peptide Receptor , 2006, Breast Cancer Research and Treatment.

[471]  E. A. Bernard,et al.  Gastrin-releasing peptide receptor antagonist effects on an animal model of sepsis. , 2006, American journal of respiratory and critical care medicine.

[472]  R. Jensen,et al.  Rottlerin inhibits stimulated enzymatic secretion and several intracellular signaling transduction pathways in pancreatic acinar cells by a non-PKC-delta-dependent mechanism. , 2006, Biochimica et biophysica acta.

[473]  中川 倫夫 Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP) , 2006 .

[474]  A. Kastin Handbook of biologically active peptides , 2006 .

[475]  E. Spindel Amphibian Bombesin-Like Peptides , 2006 .

[476]  H. Ohki‐Hamazaki,et al.  Development and function of bombesin-like peptides and their receptors. , 2005, The International journal of developmental biology.

[477]  K. Wada,et al.  Bombesin-like peptide receptor gene expression, regulation, and function in fetal murine lung. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[478]  L. Johnson Encyclopedia of Gastroenterology , 2004 .

[479]  J. Reubi,et al.  Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14). , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[480]  K. Wada,et al.  Role of bombesin (BN)-like peptides/receptors in emotional behavior by comparison of three strains of BN-like peptide receptor knockout mice , 2002, Molecular Psychiatry.

[481]  Richard,et al.  Purification and Characterization of the Bombesin / Gastrin-releasing Peptide Receptor from Swiss 3 T 3 Cells * , 2001 .

[482]  Y. Taché,et al.  Bombesin and the brain-gut axis. , 2000, Peptides.

[483]  K. Grzeschik,et al.  Significant association between a silent polymorphism in the neuromedin B gene and body weight in German children and adolescents , 2000, Acta Diabetologica.

[484]  E. Rozengurt,et al.  [D-Arg(1),D-Trp(5,7,9),Leu(11)]Substance P inhibits bombesin-induced mitogenic signal transduction mediated by both G(q) and G(12) in Swiss 3T3cells. , 2000, The Journal of biological chemistry.

[485]  E. Rozengurt G Protein-Coupled Receptors in Gastrointestinal Physiology V. Gastrointestinal peptide signaling through tyrosine phosphorylation of focal adhesion proteins * , 1998 .

[486]  F. Sundler,et al.  Insulin secretion by gastrin-releasing peptide in mice: ganglionic versus direct islet effect. , 1998, American journal of physiology. Endocrinology and metabolism.

[487]  E. Rozengurt V. Gastrointestinal peptide signaling through tyrosine phosphorylation of focal adhesion proteins. , 1998, The American journal of physiology.

[488]  A. Schally,et al.  GRHきっ坑薬のMZ‐5‐156は,ヌードマウスのDU‐145ヒトアンドロゲン非依存性前立腺癌の成長を阻害し,腫よう内のIGF2のレベル及びmRNA発現を低下させる , 1998 .

[489]  J. Benovic,et al.  The role of receptor kinases and arrestins in G protein-coupled receptor regulation. , 1998, Annual review of pharmacology and toxicology.

[490]  K. Eguchi,et al.  Serum levels of pro-gastrin-releasing peptide for follow-up of patients with small cell lung cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[491]  J. Taylor,et al.  Caudal hindbrain neuromedin B-preferring receptors participate in the control of food intake. , 1997, The American journal of physiology.

[492]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.

[493]  R. Jensen,et al.  Bombesin/GRP and vasoactive intestinal peptide/PACAP as growth factors , 1996 .

[494]  T. Moody,et al.  GRP receptors are present in non small cell lung cancer cells , 1996, Journal of cellular biochemistry. Supplement.

[495]  J. Knezetic,et al.  Bombesin may stimulate proliferation of human pancreatic cancer cells through an autocrine pathway. , 1996, International journal of cancer.

[496]  E. Sausville,et al.  Bombesin receptor structure and expression in human lung carcinoma cell lines , 1996, Journal of cellular biochemistry. Supplement.

[497]  B. Gibson,et al.  There Are Three Distinct Forms of Bombesin IDENTIFICATION OF [Leu 13 ]BOMBESIN, [Phe 13 ]BOMBESIN, AND [Ser 3 ,Arg 10 ,Phe 13 ]BOMBESIN IN THE FROG BOMBINA ORIENTALIS * , 1996 .

[498]  J. Kebabian,et al.  The Sigma-RBI handbook of receptor classification and signal transduction , 1995 .

[499]  R. Jensen,et al.  Expression and characterization of cloned human bombesin receptors. , 1995, Molecular pharmacology.

[500]  D. Horwell The 'peptoid' approach to the design of non-peptide, small molecule agonists and antagonists of neuropeptides. , 1995, Trends in biotechnology.

[501]  P. Hawkins,et al.  Activation of the small GTP-binding proteins rho and rac by growth factor receptors. , 1995, Journal of cell science.

[502]  M. Brattain,et al.  Chapter 14 – Role of Autocrine Growth Factors in Cancer Cells , 1994 .

[503]  M. Del Río,et al.  Chemoattractant capacity of bombesin, gastrin-releasing peptide and neuromedin C is mediated through PKC activation in murine peritoneal leukocytes. , 1994, Regulatory peptides.

[504]  W. Howson,et al.  'Peptoid' design. , 1994, Drug design and discovery.

[505]  R. Jensen,et al.  Bombesin receptor antagonists: different classes and cellular basis of action. , 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[506]  E. Spindel,et al.  Bombesin-like peptides: of ligands and receptors. , 1993, Recent progress in hormone research.

[507]  R. Jensen,et al.  14 - Distinguishing Bombesin Receptor Subtypes , 1993 .

[508]  T. Moran,et al.  Receptors for Bombesin-like Peptides in the Rat Central Nervous System , 1993 .

[509]  R. Jensen,et al.  Systematic development of bombesin/gastrin-releasing peptide antagonists. , 1992, Journal of the National Cancer Institute. Monographs.

[510]  H. Shapira,et al.  Molecular genetic analysis of two distinct receptors for mammalian bombesin-like peptides. , 1992, Journal of the National Cancer Institute. Monographs.

[511]  R. Jensen,et al.  Progress in the development of potent bombesin receptor antagonists. , 1991, Trends in pharmacological sciences.

[512]  G. Makhlouf,et al.  Regulation of acid secretion by bombesin/GRP neurons of the gastric fundus. , 1991, The American journal of physiology.

[513]  J. Gardner,et al.  Carbachol desensitizes pancreatic enzyme secretion by downregulation of receptors. , 1990, The American journal of physiology.

[514]  James F. Battey,et al.  Peptide growth factors and their receptors , 1990 .

[515]  C. F. Hayward,et al.  N-isobutyryl-His-Trp-Ala-Val-D-Ala-His-Leu-NHMe (ICI 216140) a potent in vivo antaconist analogue of bombesin/gastrin releasing peptide (BN/GRP) derived from the C-terminal sequence lacking the final methionine residue. , 1989, Life sciences.

[516]  Disease,et al.  Bombesin-like peptides in health and disease , 1988 .

[517]  L. Kaplan,et al.  Gastrin-releasing peptide (mammalian bombesin) gene expression in health and disease. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[518]  Bombesin-like peptides in health and disease. Nomenclature meeting. Report and recommendations. 14 October 1987. , 1988, Annals of the New York Academy of Sciences.

[519]  John D. Minna,et al.  Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer , 1985, Nature.

[520]  C. Pert,et al.  Neuropeptides are chemoattractants for human tumor cells and monocytes: a possible mechanism for metastasis. , 1985, Clinical immunology and immunopathology.

[521]  G. Habermehl,et al.  ReviewPure appl. Chem: Rinehart, K. L., et al. Marine natural products as sources of antiviral, antimicrobial, and antineoplastic Agents. 53, 795 (1981). (K. L. Rinehart, University of Illinois, Urbana, IL 61801, U.S.A.) , 1983 .

[522]  R. Jensen,et al.  Identification and characterization of receptors for secretagogues on pancreatic acinar cells. , 1981, Federation proceedings.

[523]  D. Elkind Children and adolescents : interpretive essays on Jean Piaget , 1970 .